Product NDC: | 25021-817 |
Proprietary Name: | Acetazolamide |
Non Proprietary Name: | acetazolamide sodium |
Active Ingredient(s): | 500 mg/5mL & nbsp; acetazolamide sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-817 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200880 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120615 |
Package NDC: | 25021-817-10 |
Package Description: | 1 VIAL in 1 CARTON (25021-817-10) > 5 mL in 1 VIAL |
NDC Code | 25021-817-10 |
Proprietary Name | Acetazolamide |
Package Description | 1 VIAL in 1 CARTON (25021-817-10) > 5 mL in 1 VIAL |
Product NDC | 25021-817 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | acetazolamide sodium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120615 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | ACETAZOLAMIDE SODIUM |
Strength Number | 500 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |